Pulsed Field Ablation Challenges Conventional Devices in AF
In the ADVENT trial, pulsed field ablation, a new technology for terminating drug-refractory paroxysmal AF, was noninferior to conventional thermal ablation but had potential advantages.
Medscape Medical News
source https://www.medscape.com/viewarticle/995884?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/995884?src=rss
Comments
Post a Comment